Lv41
544 积分 2025-09-17 加入
Measurable Residual Disease–Guided Therapy in Newly Diagnosed Myeloma
4天前
已完结
Isatuximab, carfilzomib, lenalidomide, and dexamethasone induction in newly diagnosed myeloma: analysis of the MIDAS trial
4天前
已完结
Isatuximab-Based Therapy for Multiple Myeloma
10天前
已完结
EuroQol 5-Dimension Questionnaire in Heart Failure With Reduced, Mildly Reduced, and Preserved Ejection Fraction
12天前
已关闭
First-line Therapy in Newly Diagnosed Multiple Myeloma
15天前
已完结
Treatment Patterns and Outcomes in Over 2200 Newly Diagnosed Multiple Myeloma Patients: Supporting Bortezomib-Lenalidomide-Dexamethasone as a Preferred Regimen in the Absence of Anti-CD38 Antibodies
15天前
已关闭
The Association of TSLP and IL-4 with Patient-Reported Outcome Measures in Chronic Rhinosinusitis with Nasal Polyps
25天前
已完结
Upper and lower airways response to tezepelumab in asthma patients with / without comorbid nasal polyposis: a 6-months reallife perspective
29天前
已关闭
The current evidence regarding the efficacy of tezepelumab administered for asthma on T2-related comorbidities
29天前
已完结
Impact of sodium-glucose cotransporter 2 inhibitor on recurrence and cardiovascular outcomes after catheter ablation for atrial fibrillation in patients with heart failure
1个月前
已完结